One of these inflammatory mediators is IL-17, in which the mRNA expression was reported to be upregulated in the mesenteric lymph node in rats following chemotherapy-induced IM [22], as well as in the inflamed mucosa of patients suffering from inflammatory bowel disease [23]. The gene discussed is IL17A; the disease is inflammatory bowel disease.